Type 2 inflammation in cystic fibrosis is a predictor of mortality and targeted with CFTR modulator therapy
Journal article published in 2024 by
Daniel P. Cook 
,
Ashley Y. Wu,
Christopher M. Thomas,
Robert G. Hamilton,
Ray Stokes Peebles,
Vern Eric Kerchberger
,
Ashley Y. Wu,
Christopher M. Thomas,
Robert G. Hamilton,
Ray Stokes Peebles,
Vern Eric Kerchberger
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 